Whole-genome sequencing of a sporadic primary immunodeficiency cohortJames Thaventhiran, Felix Boschann, Hana Lango Allen et al.|Nature|2020Cited by 242
Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disordersKate Downes, Kathleen Freson, Martin Besser et al.|Blood|2019Cited by 218
Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopeniaTadeusz Robak, Stephen Jolles, Maciej Kaźmierczak et al.|Blood Advances|2020Cited by 109
Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)Iván O. Rosas, Min Bao, Norbert Bräu et al.|EClinicalMedicine|2022Cited by 37
Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥65 years with immune thrombocytopeniaMarc Michel, Xuena Wang, Jeffrey S. Wasser et al.|Annals of Hematology|2015Cited by 30